The COOPerative Establishment for Necessary Investigation in Clinical Outcome After Stenting (COPERNICOS)
Ischemic Heart Disease
About this trial
This is an interventional treatment trial for Ischemic Heart Disease focused on measuring Ischemic Heart Disease
Eligibility Criteria
Inclusion Criteria:
- to enter COPERNICOS registry for quality assessment: Each and every patient assigned to percutaneous coronary intervention will be included.
- to enter COPERNICOS randomization: If the patient fulfil the Helsinki declaration and have a Danish personal security identification number they are asked to give written informed consent to participate in the randomized study arms.
Exclusion Criteria to randomization:
- unconscious patients
- residents in other countries thereby escaping event detection
- patients unable to understand the rationale of the study.
Sites / Locations
- Roskilde County Hospital
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm 5
Active Comparator
Active Comparator
Active Comparator
Active Comparator
Active Comparator
Study group two
Study group three
Study group four
Study group five
Study group one
Endeavor resolute drug eluting stent
The precise selection of brand name depends on negotiations with suppliers and may change during the study period
The precise selection of brand name depends on negotiations with suppliers and may change during the study period
The precise selection of brand name depends on negotiations with suppliers and may change during the study period
The precise selection of brand name depends on negotiations with suppliers and may change during the study period